
Last update at 2026-06-19T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say
Mon 12 May 25, 04:08 AMFinancial Services Roundup: Market Talk
Mon 28 Aug 23, 04:26 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 33388.67M | 22127.70M | 11658.07M | 1498.27M | 10913.84M |
| Minority interest | - | -4366.22300M | -4087.17700M | -2741.74800M | -3438.67200M |
| Net income | 27013.12M | 8431.61M | 6189.76M | 2796.61M | 7513.70M |
| Selling general administrative | - | - | - | 31026.82M | 34418.75M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 178379.98M | 134411.64M | 106115.36M | 301018.34M | 318978.97M |
| Reconciled depreciation | - | 3185.49M | 3328.66M | 3416.47M | 3456.45M |
| Ebit | 36934.34M | 25585.08M | 15421.82M | -3008.52500M | 4890.26M |
| Ebitda | 40469.62M | 28770.57M | 18750.47M | 407.94M | 8346.71M |
| Depreciation and amortization | 3535.29M | 3185.49M | 3328.66M | 3416.47M | 3456.45M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 33388.67M | 83162.71M | 47670.29M | -3008.52500M | 4890.26M |
| Other operating expenses | 144991.30M | 51248.93M | 58445.07M | 299520.07M | 308065.13M |
| Interest expense | 3545.66M | 3457.38M | 3763.75M | 3123.44M | 2381.53M |
| Tax provision | - | 9329.86M | 1381.13M | -4040.08400M | -38.53700M |
| Interest income | - | 48954.15M | 46408.95M | 50580.32M | 45969.39M |
| Net interest income | - | -3457.37800M | -3763.75200M | -3123.44000M | -2381.53200M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -3175.86000M | 9329.86M | 1381.13M | -4040.08400M | -38.53700M |
| Total revenue | 178379.98M | 134411.64M | 106115.36M | 301018.34M | 318978.97M |
| Total operating expenses | 144991.30M | 51248.93M | 58445.07M | 299520.07M | 306022.95M |
| Cost of revenue | - | - | -23714.66400M | - | - |
| Total other income expense net | - | -61035.01200M | -36012.22400M | 1765.05M | 2584.90M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | - | 12797.84M | 10276.94M | 5538.36M | 10952.37M |
| Net income applicable to common shares | - | - | - | 2796.61M | 7513.70M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1986392.67M | 1734342.01M | 1509497.49M | 1409365.57M | 1378641.97M |
| Intangible assets | 264.11M | 261.41M | 261.41M | 261.41M | 261.41M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | -926995.47800M | 161496.35M | 39720.95M | 39956.03M |
| Total liab | 1837601.51M | 1611934.56M | 1376901.83M | 1310679.39M | 1265186.01M |
| Total stockholder equity | 95145.59M | 87070.89M | 94979.63M | 75505.99M | 88066.83M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | -153441.91600M | -57252.21500M | 40426.41M | -43134.62600M | -61684.65500M |
| Common stock | 40767.43M | 40771.41M | 40771.41M | 40771.41M | 40771.41M |
| Capital stock | - | 40771.41M | 40771.41M | 40771.41M | 40771.41M |
| Retained earnings | 109041.20M | - | 77497.86M | 57622.84M | 56479.48M |
| Other liab | - | - | - | 1028885.71M | 989661.72M |
| Good will | 353.79M | 352.59M | 353.66M | 719.25M | 723.95M |
| Other assets | - | 1734342.01M | -1266069.78500M | 120626.12M | 175404.63M |
| Cash | 62002.63M | 44388.58M | 42554.40M | 42265.77M | 39945.90M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | - | - | 88377.73M | 43134.63M | 61684.65M |
| Current deferred revenue | - | - | 1059.07M | - | - |
| Net debt | 139635.28M | 37734.97M | 58875.84M | 47038.60M | 55227.65M |
| Short term debt | 153441.92M | 56674.26M | 45833.19M | 30067.30M | 48350.57M |
| Short long term debt | - | 56674.26M | 45833.19M | 30067.30M | 48350.57M |
| Short long term debt total | 201637.91M | 82123.55M | 101430.24M | 89304.37M | 95173.56M |
| Other stockholder equity | - | 46299.49M | 93489.39M | 34734.58M | 47295.42M |
| Property plant equipment | - | - | - | 41232.36M | 41155.72M |
| Total current assets | 76238.05M | - | 42554.40M | 308628.77M | 294047.96M |
| Long term investments | - | 1474337.64M | 1254462.72M | 925437.93M | 984947.34M |
| Net tangible assets | - | - | - | 74525.32M | 87081.48M |
| Short term investments | - | 880182.48M | 638098.01M | 266191.39M | 253857.58M |
| Net receivables | 14235.42M | 2302.35M | 2089.46M | 21402.18M | 71548.17M |
| Long term debt | - | 24011.39M | 53950.37M | 57443.94M | 44592.66M |
| Inventory | - | 122.07M | 125.37M | 171.61M | 244.48M |
| Accounts payable | - | - | 1196541.13M | 13067.32M | 13334.08M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -54663.03100M | - | -39281.16000M | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 62599.89M | -1529603.20200M | 1436418.34M | -980110.68000M | -909189.37900M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1910154.61M | - | 2733012.87M | 980110.68M | 909189.38M |
| Capital lease obligations | - | 1437.90M | 1646.68M | 1793.12M | 2230.33M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -95631.27000M | -130951.03600M | -80298.54300M | -150671.50400M |
| Change to liabilities | - | - | - | 2605.50M | 150.83M |
| Total cashflows from investing activities | -149351.74800M | -95631.27000M | -130951.03600M | -80298.54300M | -99620.13600M |
| Net borrowings | - | -20149.62900M | -6.43800M | -3380.35600M | 15014.74M |
| Total cash from financing activities | 1649.60M | -27910.67800M | 19785.53M | -9760.12500M | 9057.89M |
| Change to operating activities | - | - | - | 133160.36M | 166331.48M |
| Net income | 26017.19M | 22127.70M | 6189.76M | 1498.27M | 10913.84M |
| Change in cash | 9858.10M | 1834.18M | 81.97M | 2319.86M | 8639.51M |
| Begin period cash flow | 52144.53M | 42554.40M | 42472.43M | 39945.90M | 31306.39M |
| End period cash flow | 62002.63M | 44388.58M | 42554.40M | 42265.77M | 39945.90M |
| Total cash from operating activities | 156484.73M | 125949.36M | 111580.06M | 95019.05M | 98631.09M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 3535.29M | 3185.49M | 3328.66M | 3416.47M | 3456.45M |
| Other cashflows from investing activities | 47514.70M | 52141.68M | 69514.37M | 45863.32M | 43409.91M |
| Dividends paid | 1255.76M | 1078.21M | 1433.54M | -1653.24900M | -1437.60700M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | - | 6432.61M | 124807.76M | -1723.51200M | -2303.27100M |
| Sale purchase of stock | - | - | - | - | - |
| Other cashflows from financing activities | -2342.08500M | -6682.84300M | 21225.51M | 15822.15M | 16407.64M |
| Change to netincome | - | - | - | -45237.17800M | -53963.82100M |
| Capital expenditures | 5420.82M | 9711.59M | 6923.03M | 6296.18M | 4155.64M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 140323.18M | 163109.92M | 125128.47M | 134043.15M | 141624.76M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | -13390.92100M | -62473.75700M | -23066.83400M | -43938.84200M | -57363.95600M |
| Free cash flow | 151063.90M | 116237.76M | 104657.03M | 88722.87M | 94475.45M |
Sector: Financial Services Industry: Insurance - Life
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CTIHY China Taiping Insurance Holdings Co Ltd ADR |
- -% | 68.96 | 3.14 | 4.56 | 0.08 | 0.70 | 0.77 |
| CILJF China Life Insurance Co Ltd |
- -% | 3.67 | 4.18 | 5.40 | 0.44 | 1.14 | 1.41 |
| AAGIY AIA Group Ltd ADR |
0.42 1.12% | 37.91 | 18.22 | 13.87 | 4.28 | 2.59 | 2.96 |
| AAIGF AIA Group Ltd |
- -% | 9.50 | 18.21 | 13.93 | 4.20 | 2.60 | 2.96 |
| PIAIF Ping An Insurance |
- -% | 6.60 | 6.87 | 3.61 | 0.07 | 0.60 | 0.17 |
China Taiping Insurance Holdings Company Limited, an investment holding company, underwrites various insurance and reinsurance products in the People's Republic of China, Hong Kong, Macau, Singapore, and internationally. The company operates through three segments: Life Insurance Business, Property and Casualty Insurance Business, and Reinsurance Business. The Life Insurance Business segment provides life insurance products, such as corporate and personal retirement insurance, group life insurance, individual insurance, health insurance, and accident insurance products and annuities. The Property and Casualty Insurance segment offers property and casualty insurance products, including compulsory motor insurance, liability insurance, credit insurance, guarantee insurance, and short-term accident and health insurance, as well as the related reinsurance products. The Reinsurance segment provides property damage, life, marine cargo and hull, and miscellaneous non-marine reinsurance products. The company also engages in the asset management, insurance intermediary, financial leasing, property investment, and securities dealing and broking, as well as in elderly care investment businesses; manages investment funds; and provides back-to-back financing arrangement, as well as insurance broking and agency services. The company was formerly known as China Insurance International Holdings Company Limited and changed its name to China Taiping Insurance Holdings Company Limited in August 2009. The company was incorporated in 2000 and is headquartered in North Point, Hong Kong. China Taiping Insurance Holdings Company Limited is a subsidiary of China Taiping Insurance Group (HK) Co. Ltd.
China Taiping Finance Centre, North Point, Hong Kong
| Name | Title | Year Born |
|---|---|---|
| Mr. Sidong Wang | Exec. Chairman | 1961 |
| Mr. Zhaojun Yin | GM & Vice Chairman | 1965 |
| Mr. Xing Xiao | Deputy GM & Exec. Director | 1972 |
| Mr. Ruohan Zhang | CFO & Company Sec. | 1976 |
| Ms. Cynthia Choi | Head of Investor Relations | NA |
| Mr. Yanjun Jiao | Chief Internal Auditor | 1973 |
| Mr. Kedong Li | Deputy Gen. Mang. | 1968 |
| Yonghong Cheng | Deputy Gen. Mang. of Taiping Life | NA |
| Song Wu | Investment Management Department Gen. Mang. | NA |
| Mr. Zhaojun Yin | Executive Chairman | 1965 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.